Leading the way
The industry's best and brightest people are part of the Vertex team. Collectively, their decades of experience helped us launch four breakthrough medicines within seven years and will guide the way forward as we work toward bringing more transformative medicines to people living with serious diseases around the world.
The industry's best and brightest people are part of the Vertex team. Collectively, their decades of experience helped us launch four breakthrough medicines within seven years and will guide the way forward as we work toward bringing more transformative medicines to people living with serious diseases around the world.
Leader spotlight
Reshma Kewalramani, M.D., FASN
Chief Executive Officer and President
“At our core, we’re a company focused on transforming serious diseases through innovation and great science. We’ve assembled the teams, tools and technologies to deliver on our R&D strategy and to deliver for patients.”
Leadership
Our diverse leadership team includes industry luminaries and disrupters all working toward discovering tomorrow’s transformative medicines.
Board of Directors
Our Board has been a source of stability and experience that has helped guide our growth from a small research startup to a global S&P 500 company that continues to execute on its mission of investing in scientific innovation to create transformative medicines for people with serious diseases in specialty markets.
Four of our 11 (36%) Board Directors are from racial and ethnic minority groups, and four of 11 (36%) are women — these diverse perspectives combined with decades of experience will be an important source of guidance.
Committee Composition
The following table provides the committee membership for our board of directors.
Member
Chair
Lead Independent Director